featured
Topical Stabilized Cysteamine as a New Treatment for Hyperpigmentation Disorders
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Drugs in Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Topical Stabilized Cysteamine as a New Treatment for Hyperpigmentation Disorders: Melasma, Post-Inflammatory Hyperpigmentation, and Lentigines
J Drugs Dermatol 2021 Dec 01;20(12)1276-1279, S Desai, C Hartman, P Grimes, S ShahFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.